Fighting Post-COVID and ME/CFS – development of curative therapies

Carmen Scheibenbogen, Judith Theresia Bellmann-Strobl, Cornelia Heindrich^*, Kirsten Wittke, Elisa Stein, Christiana Franke, Harald Prüss, Hannah Preßler, Marie Luise Machule, Heinrich Audebert, Carsten Finke, Hanna Gwendolyn Zimmermann, Birgit Sawitzki, Christian Meisel, Markus Toelle, Anne Krueger, Anna C. Aschenbrenner, Joachim L. Schultze, Marc D. Beyer, Markus RalserMichael Mülleder, Leif Erik Sander, Frank Konietschke, Friedemann Paul, Silvia Stojanov, Lisa Bruckert, Dennis M. Hedderich, Franziska Knolle, Gabriela Riemekasten, Maria J.G.T. Vehreschild, Oliver A. Cornely, Uta Behrends, Susen Burock

^*Corresponding author for this work

Clinic of Rheumatology

Charite - Universitatsmedizin Berlin
Max Delbrück Center for Molecular Medicine
German Centre for Neurodegenerative Diseases (DZNE)
University of Bonn
Department of Cardiovascular Medicine
Technical University of Munich
Johann Wolfgang Goethe-University
University of Cologne
Partner Site Bonn-Cologne
German Centre for Infection Research (DZIF)
Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt

Fighting Post-COVID and ME/CFS – development of curative therapies

Fingerprint

Biochemistry, Genetics and Molecular Biology

Medicine and Dentistry

Immunology and Microbiology

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science